Our Commitment

We are advancing the clinical development of a pipeline of investigational therapies for patients with a range of hematological malignancies and solid tumors. When patients participate in our clinical trials and take one of our drug candidates, we recognize the time and effort it takes for patients and their families to commit to the study. So, it’s important to validate that trust by considering how each study can best contribute to the greater good of all patients. This includes not only evaluating the safety and efficacy of each drug candidate, but considering factors related to patient convenience, adoption and compliance so that patients are provided the opportunity to get the most benefit from each prospective therapy.

Clinical Trials

CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.